These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 19855436)

  • 1. Sulf-2, a heparan sulfate endosulfatase, promotes human lung carcinogenesis.
    Lemjabbar-Alaoui H; van Zante A; Singer MS; Xue Q; Wang YQ; Tsay D; He B; Jablons DM; Rosen SD
    Oncogene; 2010 Feb; 29(5):635-46. PubMed ID: 19855436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling.
    Lamanna WC; Frese MA; Balleininger M; Dierks T
    J Biol Chem; 2008 Oct; 283(41):27724-27735. PubMed ID: 18687675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SULFs, extracellular sulfatases for heparan sulfate, promote the migration of corneal epithelial cells during wound repair.
    Maltseva I; Chan M; Kalus I; Dierks T; Rosen SD
    PLoS One; 2013; 8(8):e69642. PubMed ID: 23950901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sulf-2: an extracellular modulator of cell signaling and a cancer target candidate.
    Rosen SD; Lemjabbar-Alaoui H
    Expert Opin Ther Targets; 2010 Sep; 14(9):935-49. PubMed ID: 20629619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells.
    Nawroth R; van Zante A; Cervantes S; McManus M; Hebrok M; Rosen SD
    PLoS One; 2007 Apr; 2(4):e392. PubMed ID: 17460759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of heparan sulfate sulfation in dentinogenesis.
    Hayano S; Kurosaka H; Yanagita T; Kalus I; Milz F; Ishihara Y; Islam MN; Kawanabe N; Saito M; Kamioka H; Adachi T; Dierks T; Yamashiro T
    J Biol Chem; 2012 Apr; 287(15):12217-29. PubMed ID: 22351753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene trap disruption of the mouse heparan sulfate 6-O-endosulfatase gene, Sulf2.
    Lum DH; Tan J; Rosen SD; Werb Z
    Mol Cell Biol; 2007 Jan; 27(2):678-88. PubMed ID: 17116694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of Sulfatase-2 on cancer progression and prognosis in patients with renal cell carcinoma.
    Kumagai S; Ishibashi K; Kataoka M; Oguro T; Kiko Y; Yanagida T; Aikawa K; Kojima Y
    Cancer Sci; 2016 Nov; 107(11):1632-1641. PubMed ID: 27589337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galectin-3-Binding Protein Inhibits Extracellular Heparan 6-O-Endosulfatase Sulf-2.
    Panigrahi A; Benicky J; Aljuhani R; Mukherjee P; Nováková Z; Bařinka C; Goldman R
    Mol Cell Proteomics; 2024 Jul; 23(7):100793. PubMed ID: 38825040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix detachment and proteasomal inhibitors diminish Sulf-2 expression in breast cancer cell lines and mouse xenografts.
    Khurana A; Jung-Beom D; He X; Kim SH; Busby RC; Lorenzon L; Villa M; Baldi A; Molina J; Goetz MP; Shridhar V
    Clin Exp Metastasis; 2013 Apr; 30(4):407-15. PubMed ID: 23412907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sulf-2, a proangiogenic heparan sulfate endosulfatase, is upregulated in breast cancer.
    Morimoto-Tomita M; Uchimura K; Bistrup A; Lum DH; Egeblad M; Boudreau N; Werb Z; Rosen SD
    Neoplasia; 2005 Nov; 7(11):1001-10. PubMed ID: 16331886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate specificity of 6-O-endosulfatase (Sulf-2) and its implications in synthesizing anticoagulant heparan sulfate.
    Pempe EH; Burch TC; Law CJ; Liu J
    Glycobiology; 2012 Oct; 22(10):1353-62. PubMed ID: 22692045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour-necrosis factor-α induces heparan sulfate 6-O-endosulfatase 1 (Sulf-1) expression in fibroblasts.
    Sikora AS; Hellec C; Carpentier M; Martinez P; Delos M; Denys A; Allain F
    Int J Biochem Cell Biol; 2016 Nov; 80():57-65. PubMed ID: 27693418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heparan sulfate 6-O-endosulfatases (Sulfs) coordinate the Wnt signaling pathways to regulate myoblast fusion during skeletal muscle regeneration.
    Tran TH; Shi X; Zaia J; Ai X
    J Biol Chem; 2012 Sep; 287(39):32651-64. PubMed ID: 22865881
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulf1 and Sulf2 Differentially Modulate Heparan Sulfate Proteoglycan Sulfation during Postnatal Cerebellum Development: Evidence for Neuroprotective and Neurite Outgrowth Promoting Functions.
    Kalus I; Rohn S; Puvirajesinghe TM; Guimond SE; Eyckerman-Kölln PJ; Ten Dam G; van Kuppevelt TH; Turnbull JE; Dierks T
    PLoS One; 2015; 10(10):e0139853. PubMed ID: 26448642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SULF2 methylation is prognostic for lung cancer survival and increases sensitivity to topoisomerase-I inhibitors via induction of ISG15.
    Tessema M; Yingling CM; Thomas CL; Klinge DM; Bernauer AM; Liu Y; Dacic S; Siegfried JM; Dahlberg SE; Schiller JH; Belinsky SA
    Oncogene; 2012 Sep; 31(37):4107-16. PubMed ID: 22158045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional consequences of the subdomain organization of the sulfs.
    Tang R; Rosen SD
    J Biol Chem; 2009 Aug; 284(32):21505-14. PubMed ID: 19520866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.
    Vicente CM; Lima MA; Nader HB; Toma L
    J Exp Clin Cancer Res; 2015 Mar; 34(1):25. PubMed ID: 25887999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 6-O-endosulfatase activity assay based on synthetic heparan sulfate oligomers.
    Benicky J; Sanda M; Panigrahi A; Liu J; Wang Z; Pagadala V; Su G; Goldman R
    Glycobiology; 2023 Jun; 33(5):384-395. PubMed ID: 37052463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sulfatase 2 up-regulates glypican 3, promotes fibroblast growth factor signaling, and decreases survival in hepatocellular carcinoma.
    Lai JP; Sandhu DS; Yu C; Han T; Moser CD; Jackson KK; Guerrero RB; Aderca I; Isomoto H; Garrity-Park MM; Zou H; Shire AM; Nagorney DM; Sanderson SO; Adjei AA; Lee JS; Thorgeirsson SS; Roberts LR
    Hepatology; 2008 Apr; 47(4):1211-22. PubMed ID: 18318435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.